Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 110 entries
Sorted by: Best Match Show Resources per page
The evidence for hypoperfusion as a factor in multiple sclerosis lesion development.

Multiple sclerosis international

Juurlink BH.
PMID: 23691321
Mult Scler Int. 2013;2013:598093. doi: 10.1155/2013/598093. Epub 2013 Apr 04.

The evidence that hypoxia is a precipitating factor in causing early MS lesions includes increased protein levels of hypoxia-inducible factor-1 α ; presence of the D-110 hypoxia-inducible protein; increased expression of hypoxia-inducible genes in lesions as well as in...

Cite
Juurlink BH. The evidence for hypoperfusion as a factor in multiple sclerosis lesion development. Mult Scler Int. 2013;2013:598093doi: 10.1155/2013/598093.
Juurlink, B. H. (2013). The evidence for hypoperfusion as a factor in multiple sclerosis lesion development. Multiple sclerosis international, 2013598093. https://doi.org/10.1155/2013/598093
Juurlink, Bernhard H J. "The evidence for hypoperfusion as a factor in multiple sclerosis lesion development." Multiple sclerosis international vol. 2013 (2013): 598093. doi: https://doi.org/10.1155/2013/598093
Juurlink BH. The evidence for hypoperfusion as a factor in multiple sclerosis lesion development. Mult Scler Int. 2013;2013:598093. doi: 10.1155/2013/598093. Epub 2013 Apr 04. PMID: 23691321; PMCID: PMC3649777.
Copy Download .nbib Format: NLM
[La prescription d'opioïdes: un substitut au manque de ressources en contrôle de la douleur].

Canadian family physician Medecin de famille canadien

Finestone HM, Juurlink DN, Power B, Gomes T, Pimlott N.
PMID: 27303017
Can Fam Physician. 2016 Jun;62(6):e287-90.

No abstract available.

Cite
Finestone HM, Juurlink DN, Power B, et al. [La prescription d'opioïdes: un substitut au manque de ressources en contrôle de la douleur]. Can Fam Physician. 2016;62(6):e287-90
Finestone, H. M., Juurlink, D. N., Power, B., Gomes, T., & Pimlott, N. (2016). [La prescription d'opioïdes: un substitut au manque de ressources en contrôle de la douleur]. Canadian family physician Medecin de famille canadien, 62(6), e287-90.
Finestone, Hillel M, et al. "[La prescription d'opioïdes: un substitut au manque de ressources en contrôle de la douleur]." Canadian family physician Medecin de famille canadien vol. 62,6 (2016): e287-90.
Finestone HM, Juurlink DN, Power B, Gomes T, Pimlott N. [La prescription d'opioïdes: un substitut au manque de ressources en contrôle de la douleur]. Can Fam Physician. 2016 Jun;62(6):e287-90. French. PMID: 27303017; PMCID: PMC4907568.
Copy Download .nbib Format: NLM
Availability of naloxone in Canadian pharmacies:a population-based survey.

CMAJ open

Cressman AM, Mazereeuw G, Guan Q, Jia W, Gomes T, Juurlink DN.
PMID: 29117991
CMAJ Open. 2017 Nov 08;5(4):E779-E784. doi: 10.9778/cmajo.20170123.

BACKGROUND: Naloxone is life-saving when administered after opioid overdose. In March 2016, the Canadian government made the antidote available without prescription, but anecdotal reports suggest members of the public have difficulty in procuring it. We examined the availability of...

Cite
Cressman AM, Mazereeuw G, Guan Q, et al. Availability of naloxone in Canadian pharmacies:a population-based survey. CMAJ Open. 2017;5(4):E779-E784doi: 10.9778/cmajo.20170123.
Cressman, A. M., Mazereeuw, G., Guan, Q., Jia, W., Gomes, T., & Juurlink, D. N. (2017). Availability of naloxone in Canadian pharmacies:a population-based survey. CMAJ open, 5(4), E779-E784. https://doi.org/10.9778/cmajo.20170123
Cressman, Alex M, et al. "Availability of naloxone in Canadian pharmacies:a population-based survey." CMAJ open vol. 5,4 (2017): E779-E784. doi: https://doi.org/10.9778/cmajo.20170123
Cressman AM, Mazereeuw G, Guan Q, Jia W, Gomes T, Juurlink DN. Availability of naloxone in Canadian pharmacies:a population-based survey. CMAJ Open. 2017 Nov 08;5(4):E779-E784. doi: 10.9778/cmajo.20170123. PMID: 29117991; PMCID: PMC5741422.
Copy Download .nbib Format: NLM
Impact of legislation and a prescription monitoring program on the prevalence of potentially inappropriate prescriptions for monitored drugs in Ontario: a time series analysis.

CMAJ open

Gomes T, Juurlink D, Yao Z, Camacho X, Paterson JM, Singh S, Dhalla I, Sproule B, Mamdani M.
PMID: 25485251
CMAJ Open. 2014 Oct 01;2(4):E256-61. doi: 10.9778/cmajo.20140027. eCollection 2014 Oct.

BACKGROUND: The increased use of opioid analgesics, sedative hypnotics and stimulants, coupled with the associated risks of overdose have raised concerns around the inappropriate prescribing of these monitored drugs. We assessed the impact of new legislation, the Narcotics Safety...

Cite
Gomes T, Juurlink D, Yao Z, et al. Impact of legislation and a prescription monitoring program on the prevalence of potentially inappropriate prescriptions for monitored drugs in Ontario: a time series analysis. CMAJ Open. 2014;2(4):E256-61doi: 10.9778/cmajo.20140027.
Gomes, T., Juurlink, D., Yao, Z., Camacho, X., Paterson, J. M., Singh, S., Dhalla, I., Sproule, B., & Mamdani, M. (2014). Impact of legislation and a prescription monitoring program on the prevalence of potentially inappropriate prescriptions for monitored drugs in Ontario: a time series analysis. CMAJ open, 2(4), E256-61. https://doi.org/10.9778/cmajo.20140027
Gomes, Tara, et al. "Impact of legislation and a prescription monitoring program on the prevalence of potentially inappropriate prescriptions for monitored drugs in Ontario: a time series analysis." CMAJ open vol. 2,4 (2014): E256-61. doi: https://doi.org/10.9778/cmajo.20140027
Gomes T, Juurlink D, Yao Z, Camacho X, Paterson JM, Singh S, Dhalla I, Sproule B, Mamdani M. Impact of legislation and a prescription monitoring program on the prevalence of potentially inappropriate prescriptions for monitored drugs in Ontario: a time series analysis. CMAJ Open. 2014 Oct 01;2(4):E256-61. doi: 10.9778/cmajo.20140027. eCollection 2014 Oct. PMID: 25485251; PMCID: PMC4251507.
Copy Download .nbib Format: NLM
Neonatal opioid withdrawal and antenatal opioid prescribing.

CMAJ open

Turner SD, Gomes T, Camacho X, Yao Z, Guttmann A, Mamdani MM, Juurlink DN, Dhalla IA.
PMID: 25844370
CMAJ Open. 2015 Jan 13;3(1):E55-61. doi: 10.9778/cmajo.20140065. eCollection 2015.

BACKGROUND: The incidence of neonatal opioid withdrawal is increasing in both Canada and the United States. However, the degree to which the treatment of pain with opioids, rather than the misuse of prescription opioids or heroin, contributes to the...

Cite
Turner SD, Gomes T, Camacho X, et al. Neonatal opioid withdrawal and antenatal opioid prescribing. CMAJ Open. 2015;3(1):E55-61doi: 10.9778/cmajo.20140065.
Turner, S. D., Gomes, T., Camacho, X., Yao, Z., Guttmann, A., Mamdani, M. M., Juurlink, D. N., & Dhalla, I. A. (2015). Neonatal opioid withdrawal and antenatal opioid prescribing. CMAJ open, 3(1), E55-61. https://doi.org/10.9778/cmajo.20140065
Turner, Suzanne D, et al. "Neonatal opioid withdrawal and antenatal opioid prescribing." CMAJ open vol. 3,1 (2015): E55-61. doi: https://doi.org/10.9778/cmajo.20140065
Turner SD, Gomes T, Camacho X, Yao Z, Guttmann A, Mamdani MM, Juurlink DN, Dhalla IA. Neonatal opioid withdrawal and antenatal opioid prescribing. CMAJ Open. 2015 Jan 13;3(1):E55-61. doi: 10.9778/cmajo.20140065. eCollection 2015. PMID: 25844370; PMCID: PMC4382031.
Copy Download .nbib Format: NLM
Nutritional regulation of glutathione in stroke.

Neurotoxicity research

Paterson PG, Juurlink BH.
PMID: 12835106
Neurotox Res. 1999 Dec;1(2):99-112. doi: 10.1007/BF03033274.

In contrast to cardiovascular disease, the impact of nutritional status on the prevention and outcome of stroke has received limited investigation. We present a mechanism based on animal studies, clinical data, and epidemiological data by which protein-energy status in...

Cite
Paterson PG, Juurlink BH. Nutritional regulation of glutathione in stroke. Neurotox Res. 1999;1(2):99-112doi: 10.1007/BF03033274.
Paterson, P. G., & Juurlink, B. H. (1999). Nutritional regulation of glutathione in stroke. Neurotoxicity research, 1(2), 99-112. https://doi.org/10.1007/BF03033274
Paterson, P G, and Juurlink, B H. "Nutritional regulation of glutathione in stroke." Neurotoxicity research vol. 1,2 (1999): 99-112. doi: https://doi.org/10.1007/BF03033274
Paterson PG, Juurlink BH. Nutritional regulation of glutathione in stroke. Neurotox Res. 1999 Dec;1(2):99-112. doi: 10.1007/BF03033274. PMID: 12835106; PMCID: PMC7101719.
Copy Download .nbib Format: NLM
The interaction of water with Ni(111) and H/Ni(111) studied by TPD and HREELS.

Physical chemistry chemical physics : PCCP

Shan J, Aarts JF, Kleyn AW, Juurlink LB.
PMID: 18404230
Phys Chem Chem Phys. 2008 Apr 28;10(16):2227-32. doi: 10.1039/b718266j. Epub 2008 Feb 29.

We have used temperature-programmed desorption in combination with specular and off-specular high resolution electron energy loss spectroscopy to study the interaction of H(2)O and D(2)O with the bare and hydrogen-covered Ni(111) surface. Our results for the bare metal surface...

Cite
Shan J, Aarts JF, Kleyn AW, et al. The interaction of water with Ni(111) and H/Ni(111) studied by TPD and HREELS. Phys Chem Chem Phys. 2008;10(16):2227-32doi: 10.1039/b718266j.
Shan, J., Aarts, J. F., Kleyn, A. W., & Juurlink, L. B. (2008). The interaction of water with Ni(111) and H/Ni(111) studied by TPD and HREELS. Physical chemistry chemical physics : PCCP, 10(16), 2227-32. https://doi.org/10.1039/b718266j
Shan, Junjun, et al. "The interaction of water with Ni(111) and H/Ni(111) studied by TPD and HREELS." Physical chemistry chemical physics : PCCP vol. 10,16 (2008): 2227-32. doi: https://doi.org/10.1039/b718266j
Shan J, Aarts JF, Kleyn AW, Juurlink LB. The interaction of water with Ni(111) and H/Ni(111) studied by TPD and HREELS. Phys Chem Chem Phys. 2008 Apr 28;10(16):2227-32. doi: 10.1039/b718266j. Epub 2008 Feb 29. PMID: 18404230.
Copy Download .nbib Format: NLM
Hydrophobic interactions between water and pre-adsorbed D on the stepped Pt(533) surface.

Physical chemistry chemical physics : PCCP

van der Niet MJ, Dominicus I, Koper MT, Juurlink LB.
PMID: 19039351
Phys Chem Chem Phys. 2008 Dec 21;10(47):7169-79. doi: 10.1039/b809652j. Epub 2008 Oct 20.

We have studied the interaction of Pt(533) with varying coverages of water and varying coverages of pre-adsorbed deuterium (Dad) under ultra-high vacuum conditions. We use temperature-programmed desorption and reflective absorption infrared spectroscopy techniques to study the properties of these...

Cite
van der Niet MJ, Dominicus I, Koper MT, et al. Hydrophobic interactions between water and pre-adsorbed D on the stepped Pt(533) surface. Phys Chem Chem Phys. 2008;10(47):7169-79doi: 10.1039/b809652j.
van der Niet, M. J., Dominicus, I., Koper, M. T., & Juurlink, L. B. (2008). Hydrophobic interactions between water and pre-adsorbed D on the stepped Pt(533) surface. Physical chemistry chemical physics : PCCP, 10(47), 7169-79. https://doi.org/10.1039/b809652j
van der Niet, Maria J T C, et al. "Hydrophobic interactions between water and pre-adsorbed D on the stepped Pt(533) surface." Physical chemistry chemical physics : PCCP vol. 10,47 (2008): 7169-79. doi: https://doi.org/10.1039/b809652j
van der Niet MJ, Dominicus I, Koper MT, Juurlink LB. Hydrophobic interactions between water and pre-adsorbed D on the stepped Pt(533) surface. Phys Chem Chem Phys. 2008 Dec 21;10(47):7169-79. doi: 10.1039/b809652j. Epub 2008 Oct 20. PMID: 19039351.
Copy Download .nbib Format: NLM
Co-adsorption of O and H(2)O on nanostructured platinum surfaces: Does OH form at steps?.

Angewandte Chemie (International ed. in English)

van der Niet MJ, den Dunnen A, Juurlink LB, Koper MT.
PMID: 20677191
Angew Chem Int Ed Engl. 2010 Sep 03;49(37):6572-5. doi: 10.1002/anie.201002124.

No abstract available.

Cite
van der Niet MJ, den Dunnen A, Juurlink LB, et al. Co-adsorption of O and H(2)O on nanostructured platinum surfaces: Does OH form at steps?. Angew Chem Int Ed Engl. 2010;49(37):6572-5doi: 10.1002/anie.201002124.
van der Niet, M. J., den Dunnen, A., Juurlink, L. B., & Koper, M. T. (2010). Co-adsorption of O and H(2)O on nanostructured platinum surfaces: Does OH form at steps?. Angewandte Chemie (International ed. in English), 49(37), 6572-5. https://doi.org/10.1002/anie.201002124
van der Niet, Maria J T C, et al. "Co-adsorption of O and H(2)O on nanostructured platinum surfaces: Does OH form at steps?." Angewandte Chemie (International ed. in English) vol. 49,37 (2010): 6572-5. doi: https://doi.org/10.1002/anie.201002124
van der Niet MJ, den Dunnen A, Juurlink LB, Koper MT. Co-adsorption of O and H(2)O on nanostructured platinum surfaces: Does OH form at steps?. Angew Chem Int Ed Engl. 2010 Sep 03;49(37):6572-5. doi: 10.1002/anie.201002124. PMID: 20677191.
Copy Download .nbib Format: NLM
Dynamics of hydrogen dissociation on stepped platinum.

The Journal of chemical physics

Groot IM, Schouten KJ, Kleyn AW, Juurlink LB.
PMID: 19071939
J Chem Phys. 2008 Dec 14;129(22):224707. doi: 10.1063/1.3040268.

We have studied the reactivity of hydrogen on the Pt(211) stepped surface using supersonic molecular beam techniques. We observe an energy dependence that is indicative of indirect adsorption below 9 kJ mol(-1) and direct adsorption between 0 and 37...

Cite
Groot IM, Schouten KJ, Kleyn AW, et al. Dynamics of hydrogen dissociation on stepped platinum. J Chem Phys. 2008;129(22):224707doi: 10.1063/1.3040268.
Groot, I. M., Schouten, K. J., Kleyn, A. W., & Juurlink, L. B. (2008). Dynamics of hydrogen dissociation on stepped platinum. The Journal of chemical physics, 129(22), 224707. https://doi.org/10.1063/1.3040268
Groot, I M N, et al. "Dynamics of hydrogen dissociation on stepped platinum." The Journal of chemical physics vol. 129,22 (2008): 224707. doi: https://doi.org/10.1063/1.3040268
Groot IM, Schouten KJ, Kleyn AW, Juurlink LB. Dynamics of hydrogen dissociation on stepped platinum. J Chem Phys. 2008 Dec 14;129(22):224707. doi: 10.1063/1.3040268. PMID: 19071939.
Copy Download .nbib Format: NLM
Does gastric acid suppression increase the risk of community-acquired pneumonia?.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne

Detsky ME, Juurlink DN.
PMID: 15684114
CMAJ. 2005 Feb 01;172(3):331. doi: 10.1503/cmaj.045258.

No abstract available.

Cite
Detsky ME, Juurlink DN. Does gastric acid suppression increase the risk of community-acquired pneumonia?. CMAJ. 2005;172(3):331doi: 10.1503/cmaj.045258.
Detsky, M. E., & Juurlink, D. N. (2005). Does gastric acid suppression increase the risk of community-acquired pneumonia?. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 172(3), 331. https://doi.org/10.1503/cmaj.045258
Detsky, Michael E, and Juurlink, David N. "Does gastric acid suppression increase the risk of community-acquired pneumonia?." CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne vol. 172,3 (2005): 331. doi: https://doi.org/10.1503/cmaj.045258
Detsky ME, Juurlink DN. Does gastric acid suppression increase the risk of community-acquired pneumonia?. CMAJ. 2005 Feb 01;172(3):331. doi: 10.1503/cmaj.045258. PMID: 15684114; PMCID: PMC545755.
Copy Download .nbib Format: NLM
Patients treated with aspirin after a first myocardial infarction who also receive a proton pump inhibitor have a higher incidence of cardiovascular events.

Evidence-based medicine

Juurlink DN.
PMID: 22108076
Evid Based Med. 2012 Feb;17(1):33-4. doi: 10.1136/ebmed.2011.100263. Epub 2011 Nov 22.

No abstract available.

Cite
Juurlink DN. Patients treated with aspirin after a first myocardial infarction who also receive a proton pump inhibitor have a higher incidence of cardiovascular events. Evid Based Med. 2011;17(1):33-4doi: 10.1136/ebmed.2011.100263.
Juurlink, D. N. (2012). Patients treated with aspirin after a first myocardial infarction who also receive a proton pump inhibitor have a higher incidence of cardiovascular events. Evidence-based medicine, 17(1), 33-4. https://doi.org/10.1136/ebmed.2011.100263
Juurlink, David N. "Patients treated with aspirin after a first myocardial infarction who also receive a proton pump inhibitor have a higher incidence of cardiovascular events." Evidence-based medicine vol. 17,1 (2012): 33-4. doi: https://doi.org/10.1136/ebmed.2011.100263
Juurlink DN. Patients treated with aspirin after a first myocardial infarction who also receive a proton pump inhibitor have a higher incidence of cardiovascular events. Evid Based Med. 2012 Feb;17(1):33-4. doi: 10.1136/ebmed.2011.100263. Epub 2011 Nov 22. PMID: 22108076.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 110 entries